NICE recommends routine access to beta interferon drug for MS
Multiple sclerosis patients to have routine access to beta interferon…
Multiple sclerosis patients to have routine access to beta interferon drug, says NICE in new draft guidance.
List view / Grid view
Multiple sclerosis patients to have routine access to beta interferon…
Multiple sclerosis patients to have routine access to beta interferon drug, says NICE in new draft guidance.
NICE has recommended sorafenib to be routinely available for patients on…
NICE has recommended sorafenib to be routinely available for patients on the NHS making it one of the 24 drugs appraised from the CDF...
The National Institute for Health and Care Excellence (NICE) has issued…
The National Institute for Health and Care Excellence (NICE) has issued final guidance recommending cabozantinib for some kidney cancer patients